Find News

Filter articles

Applied Filters

Showing 91 to 100 of 957 results

Argentum can't bring Gilenya patent challenge

28-04-2020Rory O'Neill

Argentum Pharmaceuticals can’t have a Novartis patent for a multiple sclerosis drug invalidated because it doesn’t have standing to bring the challenge, the US Court of Appeals for the Federal Circuit has ruled.

Pfizer fails to establish standing for patent challenge

US28-04-2020Rory O'Neill

Pfizer has been rebuked by judges for filing thin evidence in support of what the pharma company called its ‘self-evident’ standing to bring a patent challenge.

Fed Circuit rejects Biogen’s plea in MS drug dispute

US23-04-2020Sarah Morgan

The US Court of Appeals for the Federal Circuit has affirmed a lower court’s decision which found that Banner Life Sciences wasn’t infringing a Biogen patent with its bioequivalent version of a multiple sclerosis drug. 

States join antitrust suit against ‘pharma bro’ Shkreli

US16-04-2020Sarah Morgan

Six state attorneys have joined a suit filed against incarcerated ‘pharma bro’ Martin Shkreli and his company Vyera Pharmaceuticals for allegedly monopolising the market for a life-saving drug.

Indian NGO wants Gilead patents cancelled

Asia, India15-04-2020Rory O'Neill

An association representing Indian cancer patients has asked the country’s government to cancel Gilead Sciences’ patents on remdesivir, the experimental antiviral which is hoped can be used to treat coronavirus.

Shkreli wants Thiola antitrust claims thrown out


Notorious ‘pharma bro’ Martin Shkreli and his former drug company Retrophin want antitrust claims filed against them in federal court dismissed.

BIO moves 2020 international convention online

US06-04-2020Sarah Morgan

The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.

Gilead told to waive remdesivir patent rights

International02-04-2020Rory O'Neill

Almost 150 health and poverty activist campaigns, including Médecins Sans Frontières, have urged Gilead Sciences to waive patent and exclusivity rights for potential COVID-19 treatment remdesivir.

Amarin suffers defeat over Vascepa patents

US01-04-2020Sarah Morgan

A US judge has opened the door to generic versions of heart disease drug Vascepa, after invalidating Amarin’s key patents covering the drug. 

Canada authorises compulsory licences for COVID-19 shortfalls

Canada27-03-2020Rory O'Neill

Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.

Showing 91 to 100 of 957 results